Qureight – Discover Pharma

Welcome to Discover Pharma! Today is : March 12, 2026

Qureight

Clinical Development,Clinical Trials,Digital Health,Healthcare leadership,Movers & Shakers
Qureight names Rebecca Simmons COO to lead operational scaling
Qureight has appointed Rebecca Simmons as chief operating officer, strengthening [...]

January 14, 2026
Clinical Development,Clinical Trials,Digital Health,Healthcare leadership,Movers & Shakers
Qureight appoints Steven Bishop as Chief Medical Officer
Qureight has appointed Steven Bishop as chief medical officer, marking [...]

January 14, 2026
Artificial Intelligence,Clinical Trials
Qureight AI imaging to power Calluna’s Phase 2 IPF trial
Qureight, a techbio company advancing the understanding of lung and [...]

August 27, 2025
Artificial Intelligence,Clinical Development,Clinical Trials,Drug Development,Rare Diseases
AI validation of rentosertib efficacy supports global trial expansion in IPF
Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]

July 16, 2025
Clinical Trials
Rein Therapeutics to integrate Qureight’s Deep-Learning Imaging Platform in Upcoming IPF Trial
May 5, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK